Article ID Journal Published Year Pages File Type
6190342 Cancer Treatment and Research Communications 2016 5 Pages PDF
Abstract
Immunotherapy with DC vaccine and CIK cells might induce an immune response against NSCLC, improve QOL, and offer a survival benefit without severe toxicity in NSCLC patients, compared to radiotherapy.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
A comparison of clinical outcomes between radiotherapy and autoimmune cells therapy in non-small cell lung cancer patients
Authors
, , , , , , ,